Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Accepted version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/283573

Repository DOI

https://doi.org/10.17863/CAM.30935

Files

Accepted version (69.5 KB)

Type

Authors

Lennox, Belinda R

https://orcid.org/0000-0002-4972-8786

Tomei, Giuliano

Vincent, Sally-Anne

Yeeles, Ksenija

Pollard, Rebecca

Keywords

NMDA, neuroimmunology, schizophrenia, Adolescent, Adult, Antibodies, Feasibility Studies, Female, Humans, Immunoglobulins, Intravenous, Immunologic Factors, Immunotherapy, Male, Potassium Channels, Voltage-Gated, Psychotic Disorders, Receptors, GABA-A, Receptors, N-Methyl-D-Aspartate, Young Adult

Journal Title

J Neurol Neurosurg Psychiatry

Journal ISSN

0022-3050
1468-330X

Volume Title

90

Publisher

BMJ

Publisher DOI

https://doi.org/10.1136/jnnp-2018-318124

Rights and licensing

All rights reserved

Except where otherwised noted, this item's license is described as All rights reserved

Sponsorship

Stanley Medical Research Institute (SMRI) (14T-004)
Medical Research Council (MR/N019067/1)
Medical Research Council (MR/J012939/1)

Collections

University of Cambridge Research Outputs (Articles and Conferences)